Features | Partner Sites | Information | LinkXpress
Sign In
RANDOX LABORATORIES
FOCUS DIAGNOSTICS, INC.
GLOBETECH PUBLISHING

Known Lung Cancer Oncogenes Drive Colorectal Cancer

By Labmedica International staff writers
Posted on 09 Jan 2014
Image: A positive test with the Break Apart fluorescence in situ hybridization (FISH) Probe kit for anaplastic lymphoma kinase gene (ALK) (Photo courtesy of Abbott Molecular).
Image: A positive test with the Break Apart fluorescence in situ hybridization (FISH) Probe kit for anaplastic lymphoma kinase gene (ALK) (Photo courtesy of Abbott Molecular).
Activation of tyrosine kinase proto-oncogenes, through gene fusions, has been found in lung adenocarcinomas and they are highly sensitive to selective kinase inhibitors.

A fluorescence in situ hybridization (FISH) assay was used to simultaneously determine the genomic status of anaplastic lymphoma kinase (ALK) and v-ros avian UR2 sarcoma virus oncogene homolog (ROS1) and to identify the presence of genetic rearrangements in human colorectal adenocarcinoma (CRC) specimens.

Scientists at the University of Colorado School of Medicine (Aurora, CO, USA) used a FISH assay to test for the oncogenic gene rearrangements in 236 tumor samples of colorectal cancer collected from patients enrolled in a large, Australian clinical trial. The tissue microarrays (TMA) were prepared using formalin fixed paraffin embedded (FFPE) CRC tissue specimens from 268 patients.

The TMA slides were subjected to a FISH assay using a novel 4-color, 4-target ALK/ROS1 Break Apart probe (Abbott Molecular; Des Plaines, IL, USA) developed to determine genomic status of ALK and ROS1 in the same cells. The FISH assays were performed using the Zymed Spot-Light Tissue Pretreatment kit (Invitrogen; Carlsbad, CA, USA) in the TMAs. To identify the fusion partner for ALK and ROS1, reverse transcriptase polymerase chain reaction (RT-PCR) was carried out using the Invitrogen SuperScript III First-Strand Synthesis System with previously published ALK and ROS1 primers.

The scientists found one patient carrying the ALK rearrangement, confirming previous findings, and demonstrated the first finding of ROS1 as an oncogenic driver of colorectal cancer; in this case, they found it in 2 of the 236 tumor samples. Surprisingly, these gene alterations tended to coexist in colorectal tumors along with other molecular alterations. Tumors that were positive for ALK rearrangements were also positive for another well-defined molecular alternation known as Kirsten ras oncogene homolog (KRAS). ROS1 mutations occurred in one specimen along with the known, oncogenic mutation, v-raf murine sarcoma viral oncogene homolog B (BRAF).

Dara Aisner, MD, PhD, a molecular pathologist, and lead author said, “This is a case in which we have all the background science as we know that when ALK and ROS1 improperly fuse with other genes, the result can be oncogenic. We have drugs that target these oncogenes and we even have tests to determine who has the gene rearrangements and so should benefit from these drugs. The important piece missing was finding these oncogenes in other cancers, and now we've filled in that piece in colorectal cancer.” The study was published on December 2, 2013, in the journal Molecular Cancer Research.

Related Links:
University of Colorado School of Medicine
Abbott Molecular


VIRCELL
Sekisui Diagnostics
DiagCor Bioscience
comments powered by Disqus
Life Technologies

Channels

Clinical Chemistry

view channel
Image: The URiSCAN Super Plus reflectance meter (Photo courtesy of YD Diagnostics).

Semiquantitative Urine Dipstick Evaluated for Microalbuminuria Screening

The urine microalbumin test is used as a screening test for the diagnosis of renal complications in diseases, such as diabetic nephropathy, cardiovascular disease, and hypertension. A urine dipstick... Read more

Microbiology

view channel
Image: The adult free-living female Strongyloides stercoralis with a row of eggs within the body of the nematode (Photo courtesy of the CDC - Centers for Disease Control and Prevention).

Rapid Serological Assay Developed for Strongyloidiasis

Several imperfect methods exist for diagnosing strongyloidiasis and stool examination with microscopic identification of larvae considered the gold standard diagnostic procedure, showing good specificity... Read more

Pathology

view channel
Image: The BD Viper LT System for fully automated, integrated molecular testing on a table top analyzer (Photo courtesy of BD Diagnostics).

Modern Methods Accurately Detects Cervical Cancer

The newer Papanicolaou test (Pap tests) and human papilloma virus (HPV) screening more accurately identify precancerous cellular changes that potentially develop into cervical cancer. Compared to a... Read more

Lab Tech.

view channel
Image: RNAscope detects TP63 mRNA expression in human prostate tissue (Photo courtesy of Advanced Cell Diagnostics).

RNA Biomarker Assay Now Manufactured According to Strict ISO Regulatory Criteria

A line of diagnostic kits that measures RNA biomarkers with single-molecule sensitivity is now being manufactured under the stringent requirements of ISO 13485:2003 certification. Advanced Cell Diagnostics, Inc.... Read more

Industry News

view channel

Social Diagnostics Start-Up to Provide Simple, Affordable Tests Worldwide

The Royal Tropical Institute (KIT; Amsterdam, Netherlands) is establishing a nonprofit, social diagnostics company that develops and markets tests for the diagnosis of poverty-related diseases. Infectious diseases have a global impact; they take no account of national borders and influence the stability of societies... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.